Sulfatide Controls Insulin Secretion by Modulation of ATP-sensitive K+-Channel Activity and Ca2+-Dependent Exocytosis in Rat Pancreatic β-Cells

  1. Karsten Buschard1,
  2. Marianne Høy2,
  3. Krister Bokvist2,
  4. Hervør L. Olsen2,
  5. Sten Madsbad3,
  6. Pam Fredman4 and
  7. Jesper Gromada2
  1. 1Bartholin Instituttet, Kommunehospitalet, Copenhagen, Denmark
  2. 2Laboratory of Islet Cell Physiology, Novo Nordisk, Bagsværd, Denmark
  3. 3Department of Endocrinology, Hvidovre Hospital, Hvidovre, Denmark
  4. 4Department of Clinical Neuroscience, Section of Neurochemistry, University of Göteborg, Mölndals Hospital, Mölndal, Sweden

    Abstract

    The glycosphingolipid sulfatide is present in secretory granules and at the surface of pancreatic β-cells, and antisulfatide antibodies (ASA; IgG1) are found in serum from the majority of patients with newly diagnosed type 1 diabetes. Here we demonstrate that sulfatide produced a glucose- and concentration-dependent inhibition of insulin release from isolated rat pancreatic islets. This inhibition of insulin secretion was due to activation of ATP-sensitive K+-(KATP) channels in single rat β-cells. No effect of sulfatide was observed on whole-cell Ca2+-channel activity or glucose-induced elevation of cytoplasmic Ca2+ concentration. It is interesting that sulfatide stimulated Ca2+-dependent exocytosis determined by capacitance measurements and depolarized-induced insulin secretion from islets exposed to diazoxide and high external KCl. The monoclonal sulfatide antibody Sulph I as well as ASA-positive serum reduced glucose-induced insulin secretion by inhibition of Ca2+-dependent exocytosis. Our data suggest that sulfatide is important for the control of glucose-induced insulin secretion and that both an increase and a decrease in the sulfatide content have an impact on the secretory capacity of the individual β-cells.

    Footnotes

    • Address correspondence and reprint requests to Karsten Buschard, MD, Bartholin Instituttet, Kommunehospitalet, DK-1399 Copenhagen K, Denmark. E-mail: buschard{at}dadlnet.dk.

      Received for publication 14 February 2001 and accepted in revised form 25 April 2002.

      The current affiliation of K.Bo. and J.G. is Lilly Research Laboratories, Hamburg, Germany.

      ASA, antisulfatide antibodies; [Ca2+]i, free cytoplasmic Ca2+ concentration; KATP channel, ATP-sensitive K+ channel; gal-cer, galactosylceramide.

    « Previous | Next Article »Table of Contents